382.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Stryker Corp Borsa (SYK) Ultime notizie
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Surgical Booms Market Is Booming WorldwideStryker - openPR.com
Is Stryker Stock Underperforming the Nasdaq? - MSN
Is Stryker Stock Underperforming The Nasdaq? - Barchart.com
Pressure Relief Devises Industry Overview: Innovations & Key - openPR.com
Barclays maintains Stryker stock Overweight rating, $443 target By Investing.com - Investing.com South Africa
Barclays maintains Stryker stock Overweight rating, $443 target - Investing.com
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today - Benzinga
Stryker tops list of West Michigan’s largest publicly traded companies - Crain's Grand Rapids Business
Stryker's Profits Outshine Forecasts Thanks To Device Demand - Finimize
Jim Cramer on Stryker Corporation (SYK): “I Don’t Like It Enough” - Insider Monkey
Jim Cramer Had These 21 Stocks on His Radar - Insider Monkey
Stryker’s SWOT analysis: stock poised for growth amid strategic moves - Investing.com
Stryker corp VP sells shares worth $211,369 - Investing.com Australia
Stryker corp’s chief accounting officer sells $211,369 in shares By Investing.com - Investing.com South Africa
Stryker corp VP sells shares worth $211,369 By Investing.com - Investing.com Nigeria
Stryker corp’s chief accounting officer sells $211,369 in shares - Investing.com Australia
Stryker Hits Treace With Patent Suit Over Surgical Foot-Implants - Bloomberg Law News
Stryker Corporation: Is Its Tuck-in Acquisition Strategy to Ensure Market Leadership In The Med-Tech Landscape? - Smartkarma
Citigroup Raises Price Target for Stryker (SYK) to $455 | SYK Stock News - GuruFocus
Stryker wins FDA clearance for minimally invasive back pain treatment - Yahoo Finance
Stryker (SYK) Price Target Raised by Citi to $455 | SYK Stock Ne - GuruFocus
Stryker (NYSE:SYK) Expands Pain Therapy With FDA Clearance For OptaBlate BVN System - Yahoo Finance
USITC to investigate Fiagon after Stryker medical device infringement claims - MLex
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System - Yahoo Finance
Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief: Retail’s Yet To React - Investing.com India
Stryker (SYK) Gains FDA Clearance for OptaBlate System - GuruFocus
Stryker (SYK) Secures FDA Clearance for OptaBlate Nerve Ablation System | SYK Stock News - GuruFocus
Stryker’s new system aims at chronic back pain relief - Investing.com
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System – Company Announcement - Financial Times
Stryker Stock: Analyst Estimates & Ratings - Barchart.com
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System - Yahoo Finance
Stryker Inks Deal to Buy One of Its Suppliers Stryker Corp. will pay $150 million for Gaymar Indu - Medical Product Outsourcing
Boston Sci Closes Division Sale to Stryker Corp. On Jan. 3, Boston Scientific Corp. completed the - Medical Product Outsourcing
Stryker Moves to Settle DOJ Probe - Medical Product Outsourcing
Stryker’s Bone Growth Division Sold to Olympus Corp. Stryker Corp. has inked a deal to sell - Medical Product Outsourcing
Insulet Adds Stryker Executive to Board - Medical Product Outsourcing
Former Stryker CEO Receives Lifetime Achievement Award from AdvaMed - Medical Product Outsourcing
Stryker Settles for $80 Million in Unapproved Device Sales Case - Medical Product Outsourcing
Stryker Snaps Up Concentric for $135M - Medical Product Outsourcing
First-Quarter Sales Strong at Stryker Corp. - Medical Product Outsourcing
Stryker: We’re Not Buying Smith & Nephew … Yet, But We’re Interested - Medical Product Outsourcing
SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds - Yahoo Finance
Top Executive Sells Stryker Shares in Major Transaction - TipRanks
Stryker Corp Shareholders Approve Incentive Plans By Investing.com - Investing.com India
Stryker Corporation (SYK) Shareholders Approve Key Incentive Pla - GuruFocus
Stryker at Bank of America 2025 Healthcare Conference: Strategic Growth and Innovation - Investing.com
Stryker Corp Shareholders Approve Incentive Plans - Investing.com
There May Be Reason For Hope In Stryker's (NYSE:SYK) Disappointing Earnings - Yahoo Finance
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold) (NYSE:SYK) - Seeking Alpha
Why Stryker Corporation (SYK) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey
Stryker Director Makes a Multi-Million Dollar Stock Move! - TipRanks
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker (SYK) Announces Steady Dividend with Promising Growth Forecast - GuruFocus
Stryker raises dividend to $0.84 per share for Q2 - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):